
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
Neurology® Podcast
00:00
What I Will Teach My Patients About Can Mab
In an essay titled, what i will teach my patience about can mab, Dr. Aaron Carroll explains why he thinks these facts are important to know. "I think people need to know this drug isn't approved by fda as a safe and effective treatment," says Carroll. The benefit here isn't validated, is it's still uncertain,. And so they need to know just that the benefit is a small whatever that means ind this disease"
Transcript
Play full episode